Speaker illustration

Doctor Vitor Emer Egypto Rosa

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

Member of:

European Society of Cardiology

Dr Vitor Emer E. Rosa, MD, PhD, FESC, is a Cardiologist at Heart Institute (InCor) of the University of Sao Paulo, Brazil. He has a special interest in valvular heart disease. Research area: low-flow, low-gradient aortic stenosis and cardiovascular imaging.

Rheumatic myocarditis: a poorly recognized etiology of left ventricular dysfunction in valvular heart disease patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Rheumatic Heart Disease

Session: Valvular heart disease and infective endocarditis e-posters

Thumbnail

Predictors of contractile reserve on dobutamine stress echocardiography in patients with classical low-flow, low-gradient aortic stenosis

Event: ESC Congress 2019

Topic: Pathophysiology and Mechanisms

Session: Imaging in valve interventions

Thumbnail

Aortic stenosis and inappropriate myocardial hypertrophy: is there a difference related to gender?

Event: ESC Congress 2019

Topic: Pathophysiology and Mechanisms

Session: Issues surrounding aortic valves interventions

Thumbnail

Predictors of short- and mid-term outcomes after TAVR in low-flow, low-gradient aortic stenosis

Event: ESC Congress 2019

Topic: Intervention

Session: Aortic valve replacement: diagnostic and treatment considerations

Thumbnail

Impact of low-flow, low-gradient aortic stenosis in short- and long-term follow-up after TAVI: Insights from the Brazilian TAVI Registry.

Event: ESC Congress 2018

Topic: Intervention

Session: Deep dive in transcatheter aortic valve implantation

Thumbnail

Impact of interstitial myocardial fibrosis measured by T1-mapping cardiac magnetic resonance on post-operative cardiac remodeling in patients with classical low-flow, low-gradient aortic stenosis

Event: ESC Congress 2018

Topic: Pathophysiology and Mechanisms

Session: New predictors of outcome in valve disease

Thumbnail

Extracellular volume fraction for the assessment of myocardial fibrosis in patients with low-flow and low-gradient aortic stenosis with low ejection fraction

Event: ESC Congress 2017

Topic: Aortic valve disease

Session: Open questions in valvular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb